MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
QUICK SEARCH:   [advanced]


     

Molecular Pharmacology Fast Forward
First published on July 17, 2008; DOI: 10.1124/mol.108.048348
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Yin, J.-J.
Right arrow Articles by Liang, X.-J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yin, J.-J.
Right arrow Articles by Liang, X.-J.


Received for publication April 29, 2008.
Revised July 14, 2008.
Accepted for publication July 15, 2008.

Inhibition of Tumor Growth by Endohedral Metallofullerenol Nanoparticles Optimized as Reactive Oxygen Species Scavenger

Jun-Jie Yin 1, Fang Lao 2, Jie Meng 2, Peter P Fu 3, Yuliang Zhao 2, Gengmei Xing 2, XueYun Gao 4, Baoyun Sun 4, Paul C Wang 5, Chunying Chen 2, Xing-Jie Liang 2*

1 Center for Food Safety and Applied Nutrition, Food and Drug Administration 2 National Center for Nanosciences and Technology of China 3 Division of Biochemical Toxicology, National Center for Toxicological Research, Food and Drug Admini 4 Institute of High Energy Physics 5 Laboratory of Molecular Imaging, Department of Radiology, Howard University,

* Address correspondence to: E-mail: liangxj{at}nanoctr.cn

Abstract

Intraperitoneal injection of [Gd@C82(OH)22]n nanoparticles decreased activities of enzymes associated with the metabolism of reactive oxygen species (ROS) in the tumor-bearing mice. Several physiologically relevant ROS were directly scavenged by nanoparticles and lipid peroxidation was inhibited in this study. [Gd@C82(OH)22]n nanoparticles significantly reduced the electron spin resonance (ESR) signal of the stable DPPH radical measured by ESR spectroscopy. Similarly, studies using ESR with spin-trapping demonstrated efficient scavenging of superoxide radical anion (O2·-), hydroxyl radical (HO·) and singlet oxygen (1O2) by [Gd@C82(OH)22]n nanoparticles. In vitro studies using liposomes prepared from bovine liver phosphatidylcholine revealed that nanoparticles also had a strong inhibitory effect on lipid peroxidation. Consistent with their ability to scavenge ROS and inhibit lipid peroxidation, we determined that [Gd@C82(OH)22]n nanoparticles also protected cells subjected in vitro to oxidative stress. Studies using human lung adenocarcinoma cells or rat brain capillary endothelial cells demonstrated that [Gd@C82(OH)22]n nanoparticles reduced H2O2-induced ROS formation and mitochondrial damage. [Gd@C82(OH)22]n nanoparticles efficiently inhibited the growth of malignant tumors in vivo. In summary, the results obtained in this study reveal anti-tumor activities of [Gd@C82(OH)22]n nanoparticles in vitro and in vivo. As ROS are known to be implicated in the etiology of a wide range of human diseases, including cancer, the present findings demonstrate that the potent inhibition of [Gd@C82(OH)22]n nanoparticles on tumor growth likely relates with typical capacity of its reactive oxygen species scavenge.


Key words: Oxidative stress, Mechanisms of cell killing/apoptosis, Resistance




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics